EMAIL THIS PAGE TO A FRIEND

PLoS pathogens

Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague.


PMID 25974210

Abstract

Pneumonic plague is a fatal disease caused by Yersinia pestis that is associated with a delayed immune response in the lungs. Because neutrophils are the first immune cells recruited to sites of infection, we investigated the mechanisms responsible for their delayed homing to the lung. During the first 24 hr after pulmonary infection with a fully virulent Y. pestis strain, no significant changes were observed in the lungs in the levels of neutrophils infiltrate, expression of adhesion molecules, or the expression of the major neutrophil chemoattractants keratinocyte cell-derived chemokine (KC), macrophage inflammatory protein 2 (MIP-2) and granulocyte colony stimulating factor (G-CSF). In contrast, early induction of chemokines, rapid neutrophil infiltration and a reduced bacterial burden were observed in the lungs of mice infected with an avirulent Y. pestis strain. In vitro infection of lung-derived cell-lines with a YopJ mutant revealed the involvement of YopJ in the inhibition of chemoattractants expression. However, the recruitment of neutrophils to the lungs of mice infected with the mutant was still delayed and associated with rapid bacterial propagation and mortality. Interestingly, whereas KC, MIP-2 and G-CSF mRNA levels in the lungs were up-regulated early after infection with the mutant, their protein levels remained constant, suggesting that Y. pestis may employ additional mechanisms to suppress early chemoattractants induction in the lung. It therefore seems that prevention of the early influx of neutrophils to the lungs is of major importance for Y. pestis virulence. Indeed, pulmonary instillation of KC and MIP-2 to G-CSF-treated mice infected with Y. pestis led to rapid homing of neutrophils to the lung followed by a reduction in bacterial counts at 24 hr post-infection and improved survival rates. These observations shed new light on the virulence mechanisms of Y. pestis during pneumonic plague, and have implications for the development of novel therapies against this pathogen.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2502034
Anti-Cxcr2 (N-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1406027
Anti-CXCR2 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2900183
Anti-CXCR2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2103792
Anti-IL8RB, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB4501895
Anti-MMP-8, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB1406134
Anti-MMP8 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA021221
Anti-MMP8 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab1
HPA022935
Anti-MMP8 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab2
SRP3331 G-CSF from mouse, Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
SRP3263 G-CSF human, Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
SRP6164
G-CSF human, recombinant, expressed in HEK 293 cells, ≥95% (SDS-PAGE)
G8160 Granulocyte Colony-Stimulating Factor from mouse, G-CSF, recombinant, expressed in E. coli, suitable for cell culture
G0407 Granulocyte colony-stimulating factor human, G-CSF, recombinant, expressed in E. coli, suitable for cell culture
H5541 Granulocyte colony-stimulating factor human, G-CSF, recombinant, expressed in HEK 293 cells, HumanKine®, suitable for cell culture